BSX · News · 20260813N
Stock Repurchase Program
BOSTON SCIENTIFIC CORP · 2026-08-13 · Importance 58 · Surprise 42 · In source text
Boston Scientific authorized a $5 billion share-repurchase program, according to third-party reporting. The authorization was cited alongside institutional ownership activity and recent quarterly results. The digest does not specify the program’s expiration date, execution pace, or amount repurchased to date.
Key facts
- Boston Scientific authorized a $5 billion share repurchase program. source
- Y Intercept Hong Kong Ltd increased its stake in Boston Scientific by 148.8% in Q2, acquiring 670,060 additional shares to reach a total of 1.12 million shares valued at $47.8 million. source
- NewEdge Advisors LLC reduced its stake in Boston Scientific by 29.6% in the first quarter, selling 27,583 shares and retaining 65,461 shares valued at $4.1 million. source
- Fisher Funds Management LTD increased its stake in Boston Scientific by 17.1% in the second quarter, bringing its total holding to approximately $43 million. source
- CEO Michael Mahoney purchased 186,240 shares for $9 million. source
- QRG Capital Management Inc. acquired 198,951 additional shares of Boston Scientific, bringing its total holdings to 362,716 shares valued at $15.5 million. source
- Brookstone Capital Management sold 233,448 shares of Boston Scientific. source
- Institutional investors collectively own 89.07% of Boston Scientific (BSX). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -9.4% | Boston Scientific authorized a $5 billion share repurchase program. |